FOI 2090 Anti TNF Drugs

1. What is the Trust’s annual spend on anti-TNF drugs (most recent year available)?

The Trust’s annual total spend on anti-TNF drugs is £2,474,635

2. How many patients has the Trust treated with anti-TNF drugs in the last 12 months?  Please see table below.

3. What is the % split of anti-TNF patients by the following channels: Please see table below:

Number of Patients % of Patients
Inpatient 102 26%
Homecare 287 73%
Outpatient 2 1%
TOTAL 391 100%

4. How many patients has the Trust treated with the following conditions in last 12 months:  See table below for patients treated with the following conditions between 01/12/2015 – 30/11/2016.

Condition Number of Patients
Rheumatoid Arthritis 377
Crohn’s Disease 211
Psoriasis 80
Other anti-TNF Conditions  

5. Are there any gain share agreements in place between the Trust and CCGs for anti-TNF biosimilars? If yes, please provide:

Name of CCG Name of Specific Drug? Start Date of Agreement Length of Agreement Gain Share Split %

 

The Trust does not have any gain share agreements in place.

©2017 Royal Surrey County Hospital

Feedback We would love to hear from you
Send

Log in with your credentials

or    

Forgot your details?